Barinthus Biotherapeutics (BRNS) Stock Chart & Stock Price History → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free BRNS Stock Alerts $2.35 -0.08 (-3.29%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Barinthus Biotherapeutics Stock Price Performance5 Day Performance+1.29%1 Month Performance-6.93%3 Month Performance-6.37%6 Month Performance-14.55%Year-To-Date Performance-36.31% Receive BRNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Barinthus Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaThe Overlooked Retirement Asset You Probably Don’t Own4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. BRNS Stock Chart for Sunday, May, 19, 2024 BRNS Chart by TradingView Barinthus Biotherapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$2.43$2.35-3.29%$2.35$2.35375 shs$91.46 million05/16/2024$2.22$2.43+9.45%$2.43$2.275,789 shs$94.57 million05/15/2024$2.32$2.22-4.31%$2.33$2.209,472 shs$86.40 million05/14/2024$2.35$2.32-1.07%$2.35$2.266,543 shs$90.29 million05/13/2024$2.34$2.35+0.43%$2.42$2.217,495 shs$91.27 million05/10/2024$2.35$2.29-2.55%$2.45$2.278,563 shs$89.13 million Get the Latest News and Ratings for BRNS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Barinthus Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$2.27$2.35+3.52%$2.40$2.2310,227 shs$91.46 million05/08/2024$2.27$2.27$2.45$2.214,606 shs$88.35 million05/07/2024$2.21$2.27+2.71%$2.40$2.222,347 shs$88.35 million05/06/2024$2.18$2.21+1.38%$2.25$2.167,930 shs$86.02 million05/03/2024$2.20$2.18-0.91%$2.28$2.145,110 shs$84.85 million05/02/2024$2.20$2.20$2.29$2.153,060 shs$85.62 million05/01/2024$2.05$2.20+7.32%$2.25$2.0317,671 shs$85.63 million04/30/2024$2.59$2.05-20.85%$2.59$1.82175,738 shs$79.79 million04/29/2024$2.50$2.59+3.60%$2.59$2.364,158 shs$100.80 million04/26/2024$2.43$2.50+2.88%$2.60$2.406,864 shs$97.30 million04/25/2024$2.51$2.43-3.19%$2.54$2.402,824 shs$94.58 million04/24/2024$2.60$2.51-3.46%$2.61$2.505,008 shs$97.69 million04/23/2024$2.62$2.60-0.76%$2.63$2.507,993 shs$101.19 million04/22/2024$2.51$2.62+4.38%$2.66$2.5020,222 shs$101.97 million04/19/2024$2.67$2.53-5.43%$2.72$2.513,440 shs$98.27 million04/18/2024$2.60$2.67+2.69%$2.77$2.538,039 shs$103.92 million04/17/2024$2.53$2.60+2.77%$2.67$2.596,497 shs$101.19 million04/16/2024$2.64$2.53-4.24%$2.77$2.5118,051 shs$98.47 million04/15/2024$3.14$2.64-15.86%$2.97$2.6035,545 shs$102.83 million04/12/2024$3.33$3.14-5.71%$3.21$2.962,700 shs$122.21 million04/11/2024$3.23$3.33+3.10%$3.51$3.1013,170 shs$129.60 million04/10/2024$3.29$3.23-1.82%$3.40$3.1014,492 shs$125.71 million04/09/2024$3.24$3.29+1.54%$3.47$3.183,968 shs$128.05 million04/08/2024$3.30$3.24-1.82%$3.64$3.1818,097 shs$126.10 million04/05/2024$3.67$3.30-10.08%$3.67$3.3050,689 shs$128.44 million04/04/2024$2.91$3.67+26.12%$4.16$2.84164,432 shs$142.84 million04/03/2024$2.37$2.91+22.78%$3.05$2.37218,182 shs$113.26 million04/02/2024$2.45$2.37-3.27%$2.48$2.373,479 shs$91.39 million04/01/2024$2.38$2.45+2.94%$2.46$2.3820,588 shs$94.47 million03/29/2024$2.38$2.38$2.47$2.3132,846 shs$91.77 million03/28/2024$2.33$2.38+2.15%$2.47$2.3132,846 shs$91.79 million03/27/2024$2.40$2.33-2.92%$2.40$2.3130,875 shs$89.85 million03/26/2024$2.41$2.40-0.41%$2.40$2.2532,388 shs$92.54 million03/25/2024$2.58$2.41-6.59%$2.46$2.267,961 shs$92.93 millionElon’s New Device is About to Shock the World (Ad)Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake.03/22/2024$2.41$2.58+7.05%$2.60$2.3233,023 shs$99.48 million03/21/2024$2.35$2.41+2.55%$2.45$2.277,428 shs$92.93 million03/20/2024$2.41$2.35-2.49%$2.57$2.1710,496 shs$90.62 million03/19/2024$2.43$2.41-0.82%$2.52$2.3817,942 shs$92.93 million03/18/2024$2.47$2.43-1.80%$2.47$2.2713,914 shs$93.70 million03/15/2024$2.51$2.47-1.59%$2.49$2.4312,157 shs$95.24 million03/14/2024$2.55$2.51-1.56%$2.53$2.437,378 shs$96.80 million03/13/2024$2.58$2.55-1.17%$2.61$2.464,542 shs$98.32 million03/12/2024$2.66$2.58-3.01%$2.59$2.457,075 shs$99.49 million03/11/2024$2.60$2.66+2.31%$2.66$2.4789,961 shs$102.57 million03/08/2024$2.65$2.60-1.89%$2.75$2.555,275 shs$100.26 million03/07/2024$2.70$2.65-1.85%$2.80$2.532,504 shs$102.18 million03/06/2024$3.06$2.70-11.76%$2.95$2.5029,297 shs$104.11 million03/05/2024$2.95$3.06+3.73%$3.20$2.7315,143 shs$117.99 million03/04/2024$2.95$2.95$3.10$2.8724,599 shs$113.77 million03/01/2024$2.83$2.95+4.24%$3.05$2.8616,439 shs$113.75 million02/29/2024$2.82$2.83+0.35%$3.00$2.8311,865 shs$109.14 million02/28/2024$2.81$2.82+0.36%$2.92$2.7149,692 shs$108.74 million02/27/2024$2.76$2.81+1.81%$2.84$2.719,547 shs$108.35 million02/26/2024$2.69$2.76+2.60%$2.84$2.6916,599 shs$106.43 million02/23/2024$2.68$2.69+0.37%$2.76$2.5522,614 shs$103.73 million02/22/2024$2.60$2.68+3.08%$2.82$2.5810,608 shs$103.34 million02/21/2024$2.61$2.60-0.38%$2.69$2.5111,425 shs$100.26 million02/20/2024$2.51$2.61+3.98%$2.82$2.5862,380 shs$100.64 million02/19/2024$2.51$2.51$2.74$2.5012,800 shs$96.80 million Related Companies: CMRX Stock Chart ONCY Stock Chart IFRX Stock Chart SLS Stock Chart YS Stock Chart CUE Stock Chart SPRO Stock Chart ACRS Stock Chart VTVT Stock Chart ANVS Stock Chart Receive BRNS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Barinthus Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BRNS) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingBuy this small stock before coming AI Tidal WaveChaikin AnalyticsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersUrgent Nvidia WarningAltimetry41 banks launch ‘crypto dollar’Stansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Barinthus Biotherapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.